Article
Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
Clinical lymphoma, myeloma & leukemia - 1 Apr 2021
Davila-Gonzalez Daniel, Barrios-Ruiz Alanna, Fountain Eric, Cheng Lee, Masarova Lucia, Verstovsek Srdan, Rojas-Hernandez Cristhiam M
Abstract excerpt
INTRODUCTION: Considering the evolving diagnostic criteria of polycythemia vera (PV), we analyzed the utility of serum erythropoietin (EPO) as a predictive marker for differentiating polycythemia vera (PV) from other etiologies of erythrocytosis. PATIENTS AND METHODS: We conducted a retrospective study after a review of electronical medical records from January 2005 to December 2016 with diagnosis of...
Topics
- Biomarkers, Tumor
- Cancer Care Facilities
- Erythropoietin
- Female
- Genetic Testing
- Humans
- Janus Kinase 2
- Male
- Middle Aged
- Mutation
- Polycythemia
